Major Recall Alert: Azurity Pharmaceuticals Pulls One Lot of Zenzedi® 30 mg
What Happened On January 24, 2024, Azurity Pharmaceuticals, Inc. voluntarily recalled a single lot (Lot F230169A, NDC 24338‑856‑03, expiry June 2025) of Zenzedi® (dextroamphetamine sulfate) 30 mg tablets, distributed nationwide through U.S. pharmacies U.S. Food and Drug Administration+12U.S. Food and Drug Administration+12Louisiana Department of Health+12. Why the Recall Was Issued A Nebraska pharmacist discovered that a bottle labeled as […]